Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Sepracor has announced that the Omnaris Nasal Spray is now available by prescription in pharmacies in the US.
Subscribe to our email newsletter
Omnaris Nasal Spray is indicated for the treatment of nasal symptoms associated with seasonal allergic rhinitis in adults and children six years of age and older, and with perennial allergic rhinitis in adults and adolescents 12 years of age and older.
Adrian Adams, president and CEO of Sepracor, said: “We believe that Omnaris Nasal Spray is a strategically seamless fit with our proprietary portfolio of respiratory products.”